Response of Adult Patients with Osteomalacia to Treatment with Crystalline 1α-Hydroxy Vitamin D3
Authors:
- Philippe BordierPBPhilippe Bordier
- Maurice M. PechetMPMaurice M. Pechet
- Robert HesseRHRobert Hesse
- Pierre MariePMPierre Marie
- Howard RasmussenHRHoward Rasmussen
- 24 October 1974
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 291 (17) , 866-871
Abstract
Preparation of synthetic sterols with hydroxyl groups in key positions on the sterol molecule opens the possibility of developing new antirachitic sterols to treat metabolic bone disease in man. One of the first of these that has been pre-prepared in crystalline form is 1α-hydroxy vitamin D3. We examined its effects in human subjects suffering from osteomalacia. The intravenous administration of 2.5 to 5.0 μg per 24 hours of pure crystalline 1α-hydroxy vitamin D3 to four human subjects with vitamin-D-deficient osteomalacia induced a rise in serum phosphorus, an inconsistent effect on serum calcium, a decrease in urinary phosphate excretion, a decrease in the fecal excretion of both calcium and phosphorus, and a late rise in urinary hydroxyproline excretion. Phosphate clearance was decreased in all subjects. Bone biopsies were performed before and eight to 10 days after 1α-hydroxy vitamin D3 therapy. Quantitative histologic analysis showed that active bone resorption and active bone formation both increased, and the percentage of the total osteoid surface bearing a calcification front was also increased. These results indicate that 1α-hydroxy vitamin D3 is an active antirachitic agent in man. (N Engl J Med 291:866–871, 1974)Keywords
This publication has 16 references indexed in Scilit:
- ACTION OF 1α-HYDROXY VITAMIN D3 ON CALCIUM ABSORPTION AND BONE RESORPTION IN MANThe Lancet, 1974
- Convenient synthesis of crystalline 1α,25-dihydroxyvitamin D 3Journal of the Chemical Society, Chemical Communications, 1974
- 1-ALPHA-HYDROXYCHOLECALCIFEROL AS A SUBSTITUTE FOR THE KIDNEY HORMONE 1,25-DIHYDROXYCHOLECALCIFEROL IN CHRONIC RENAL FAILUREThe Lancet, 1973
- Convenient synthesis of l.alpha.-hydroxy-vitamin D3Journal of the American Chemical Society, 1973
- 25-Hydroxycholecalciferol. A COMPARATIVE STUDY IN DEFICIENCY RICKETS AND DIFFERENT TYPES OF RESISTANT RICKETSJournal of Clinical Investigation, 1972
- The synthesis of 1α,25-dihydroxycholecalciferol -- A metabolically active form of vitamin D3Tetrahedron Letters, 1972
- Studies on calciferol metabolism I. Production of vitamin D metabolite 4B from 25-OH-cholecalciferol by kidney homogenatesBiochemical and Biophysical Research Communications, 1971
- Unique Biosynthesis by Kidney of a Biologically Active Vitamin D MetaboliteNature, 1970
- The role of the liver in the metabolism of vitamin DJournal of Clinical Investigation, 1969
- A specific method for the analysis of hydroxyproline in tissues and urineAnalytical Biochemistry, 1960